Content about Warner Chilcott

May 20, 2013
Actavis, Warner Chilcott reach acquisition deal

Actavis will acquire Warner Chilcott for $8.5 billion, the drug maker said.

May 14, 2013
Actavis issues regulatory filing to comply with Irish company-takeover rules

Actavis is continuing to pursue a plan to buy Irish drug maker Warner Chilcott, as the U.S.-based company announced Tuesday its total number of shares and share-purchase options in order to comply with Ireland's merger-and-acquisition rules.

May 10, 2013
Actavis in talks to combine with Warner Chilcott

Actavis is looking into the possibility of buying Warner Chilcott, the generic drug maker said.

April 23, 2013
Warner Chilcott receives FDA approval for Minastrin 24 FE

The Food and Drug Administration has approved a new contraceptive drug made by Warner Chilcott, the drug maker said.

April 16, 2013
FDA approves 200-mg strength of Warner Chilcott antibiotic

The Food and Drug Administration has approved a new strength of an antibiotic made by Warner Chilcott, the drug maker said.

February 8, 2013
FDA approves Warner Chilcott ulcerative colitis drug

The Food and Drug Administration has approved a new drug from Warner Chilcott for treating ulcerative colitis, the drug maker said.

July 10, 2012
Reports: Mylan sues Warner Chilcott over antibiotic drug

Generic drug maker Mylan is suing Warner Chilcott and an Australian company, alleging that they illegally tried to protect one of their drugs from generic competition, according to published reports.

May 18, 2012
Watson challenges Lo Loestrin Fe patent

Generic drug maker Watson Pharmaceuticals is challenging the patent protection of a contraceptive drug made by Warner Chilcott, Watson said Friday.

December 1, 2011
Warner Chilcott sues Mylan, Famy Care over Generess Fe patent challenge

Generic drug maker Mylan and a partnering company are challenging the patent on a contraceptive drug.

October 19, 2011
Mylan settles with Warner Chilcott over generic version of Femcon Fe

Generic drug maker Mylan has settled with Warner Chilcott in a case concerning an oral contraceptive.

October 11, 2011
Zacks: Warner Chilcott can withstand generic threats

Drug maker Warner Chilcott's diversified portfolio of drugs will help it weather generic challenges to its patents, according to a new report by Zacks Investment Research.

September 22, 2011
U.S. District Court blocks Mylan's generic antibiotic

A federal court in New Jersey has blocked an attempt by Mylan to market a generic version of a drug made by Warner Chilcott.

July 26, 2011
Lupin seeks to market generic Lo Loestrin Fe

Generic drug maker Lupin is seeking approval for a generic version of a contraceptive made by Warner Chilcott, according to published reports.

April 19, 2011
Forest purchases rights to azimilide

Drug maker Forest Labs has acquired worldwide rights to a drug developed by Procter & Gamble Pharmaceuticals for treating arrhythmia.

November 7, 2010
Warner Chilcott reports Q3 revenue gain, profit drop

Quarterly revenue for Warner Chilcott during the third quarter primarily was driven by the company's...

October 11, 2010
Warner Chilcott's Atelvia receives FDA approval

The Food and Drug Administration has approved a new formulation of a drug for osteoporosis...

September 23, 2010
Warner Chilcott acquires rights to Enablex

Drug maker Warner Chilcott will buy the U.S. rights to a treatment for overactive bladder...

© 2013 Drug Store News. All Rights Reserved.